American Healthcare REIT, Inc. (AHR) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 16, 2026
Summary
American Healthcare REIT’s revenue went from $3M in fiscal 2016 to $2.3B in fiscal 2025, growth of about 107.6% a year.
Net income in fiscal 2025 was $70M, a net margin of 3.1%; the highest of the period.
Over the twelve months to September 30, 2026, revenue was $2.7B and net income $96M.
Free cash flow was -$590M in fiscal 2025 and positive in 7 of the 10 years shown.
The diluted share count rose 21213% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.7B | $2.3B | $2.1B | $1.9B | $1.4B | $1.1B | $1.1B | $1.1B | $84M | $33M | $3M |
| Gross profit | $589M | $467M | $417M | $364M | $131M | $94M | $75M | $1.1B | $73M | $26M | $2M |
| Operating income | $539M | $415M | $364M | $307M | $302M | $213M | $218M | $221M | -$2M | $3M | -$5M |
| Net income | $96M | $70M | -$38M | -$71M | -$81M | -$48M | $2M | -$5M | -$8M | $541000 | -$5M |
| EPS (diluted) | $0.49 | $0.42 | $-0.29 | $-1.08 | $-1.24 | $-0.95 | $0.05 | $-0.12 | $-0.60 | $0.08 | $-7.00 |
| R&D | — | — | — | — | — | — | — | — | — | — | — |
| Revenue growth | — | +9.2% | +10.9% | +32.2% | +25.6% | +5.1% | −2.7% | +1201.4% | +153.4% | +956.2% | — |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $422M | $294M | $176M | $99M | $148M | $18M | $219M | $117M | $15M | $12M | -$4M |
| Capital spending | -$2.5B | -$884M | -$60M | -$45M | -$8M | — | -$8M | -$6M | -$4M | -$1M | -$23000 |
| Free cash flow | -$2.0B | -$590M | $116M | $53M | $140M | — | $211M | $111M | $11M | $11M | -$4M |
| Dividends paid | $186M | $164M | $121M | $76M | $51M | $23M | $27M | $63M | $14M | $6M | $549000 |
| Buybacks | — | $0 | $14000 | $469000 | $21M | $382000 | $23M | $90M | $3M | $735000 | $0 |
| Stock-based pay | $25M | $15M | $10M | $5M | $4M | $9M | -$1M | $3M | $185000 | $131000 | $80000 |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $115M | $77M | $43M | $65M | $82M | $113M | $53M | $35M | $7M | $2M |
| Debt | — | $1.1B | $1.2B | $1.6B | $1.5B | $1.3B | $1.0B | $37M | $17M | $12M | $34M |
| Equity | — | $3.3B | $2.3B | $1.3B | $1.4B | $1.6B | $866M | $590M | $1.2B | $353M | $92M |
| Total assets | — | $5.4B | $4.5B | $4.6B | $4.8B | $4.6B | $3.2B | $1.1B | $896M | $480M | $143M |
| Shares (diluted) | 218M | 167M | 131M | 66M | 66M | 50M | 45M | 45M | 14M | 7M | 1M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 22.1% | 20.6% | 20.1% | 19.5% | 9.2% | 8.3% | 7.0% | 98.2% | 86.4% | 78.1% | 71.5% |
| Operating margin | 20.2% | 18.4% | 17.6% | 16.4% | 21.4% | 19.0% | 20.4% | 20.1% | -2.0% | 9.6% | -157.2% |
| Net margin | 3.6% | 3.1% | -1.8% | -3.8% | -5.8% | -4.2% | 0.2% | -0.4% | -9.9% | 1.6% | -173.4% |
| FCF margin | -76.7% | -26.1% | 5.6% | 2.9% | 9.9% | — | 19.7% | 10.1% | 13.2% | 33.9% | -115.5% |
| ROIC | — | 7.4% | 8.4% | 8.6% | 8.2% | 5.9% | 9.1% | 27.9% | -0.1% | 0.9% | -3.9% |
| ROE | — | 2.1% | -1.7% | -5.6% | -5.8% | -3.0% | 0.2% | -0.8% | -0.7% | 0.1% | -5.9% |
Frequently asked questions
What is American Healthcare REIT’s annual revenue?
$2.3B in fiscal 2025 and $2.7B over the twelve months to September 30, 2026.
How much profit does American Healthcare REIT make?
Net income was $70M in fiscal 2025 (net margin 3.1%).
Is American Healthcare REIT’s revenue growing?
Yes: revenue rose 9.1% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.